medroxyprogesterone has been researched along with Candidiasis, Vulvovaginal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amir, S; Fares, E; Onsy, FA; Shaala, S; Toppozada, M | 1 |
Presl, J | 1 |
Diddle, AW; Gardner, WH; O'Connor, KA; Williamson, PJ | 1 |
3 other study(ies) available for medroxyprogesterone and Candidiasis, Vulvovaginal
Article | Year |
---|---|
The protective influence of progestogen only contraception against vaginal moniliasis.
Topics: Adult; Candidiasis, Vulvovaginal; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone; Pregnancy; Time Factors; Vaginal Diseases | 1979 |
[Medroxyprogesterone acetate in the treatment of recurrent vaginal candidiasis].
Topics: Candidiasis, Vulvovaginal; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Recurrence | 1988 |
Oral contraceptive medications and vulvovaginal candidiasis.
Topics: Adult; Androstanes; Balanitis; Candidiasis, Vulvovaginal; Chlormadinone Acetate; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Male; Medroxyprogesterone; Mestranol; Middle Aged; Norethindrone; Norethynodrel | 1969 |